Chicago Equity Partners LLC raised its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 591.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 41,555 shares of the company’s stock after acquiring an additional 35,545 shares during the period. Chicago Equity Partners LLC’s holdings in AmerisourceBergen were worth $3,816,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of the business. First Merchants Corp raised its stake in AmerisourceBergen by 160.5% during the third quarter. First Merchants Corp now owns 27,342 shares of the company’s stock valued at $2,262,000 after buying an additional 16,848 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its holdings in shares of AmerisourceBergen by 23.3% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,459 shares of the company’s stock valued at $369,000 after purchasing an additional 842 shares during the last quarter. Wedge Capital Management L L P NC grew its holdings in shares of AmerisourceBergen by 17.3% during the third quarter. Wedge Capital Management L L P NC now owns 494,216 shares of the company’s stock valued at $40,896,000 after purchasing an additional 72,743 shares during the last quarter. Achmea Investment Management B.V. grew its holdings in shares of AmerisourceBergen by 7.8% during the second quarter. Achmea Investment Management B.V. now owns 29,338 shares of the company’s stock valued at $2,770,000 after purchasing an additional 2,123 shares during the last quarter. Finally, Burgundy Asset Management Ltd. grew its holdings in AmerisourceBergen by 3.3% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 2,649,123 shares of the company’s stock worth $250,422,000 after buying an additional 84,163 shares in the last quarter. Institutional investors own 67.57% of the company’s stock.
A number of equities analysts recently issued reports on the company. Zacks Investment Research lowered AmerisourceBergen from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Needham & Company LLC decreased their price target on AmerisourceBergen from $117.00 to $113.00 and set a “buy” rating for the company in a research note on Thursday. Jefferies Group set a $85.00 price target on AmerisourceBergen and gave the company a “hold” rating in a research note on Sunday, October 29th. Goldman Sachs Group raised AmerisourceBergen from a “neutral” rating to a “buy” rating in a research note on Friday, December 15th. Finally, Leerink Swann set a $105.00 price target on AmerisourceBergen and gave the company a “buy” rating in a research note on Tuesday, January 2nd. One analyst has rated the stock with a sell rating, six have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. AmerisourceBergen has an average rating of “Buy” and a consensus price target of $101.17.
AmerisourceBergen Corp. (ABC) traded down $2.36 during trading on Friday, reaching $89.19. 3,670,831 shares of the company’s stock traded hands, compared to its average volume of 1,913,078. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.95 and a quick ratio of 0.48. The firm has a market capitalization of $19,592.28, a P/E ratio of 14.67, a price-to-earnings-growth ratio of 1.43 and a beta of 1.02. AmerisourceBergen Corp. has a 52-week low of $71.90 and a 52-week high of $106.27.
AmerisourceBergen (NYSE:ABC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.35 by $0.20. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The company had revenue of $40.47 billion for the quarter, compared to the consensus estimate of $40.42 billion. During the same period last year, the business posted $1.36 earnings per share. The firm’s revenue was up 6.0% compared to the same quarter last year. equities research analysts forecast that AmerisourceBergen Corp. will post 6.58 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th will be paid a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a yield of 1.70%. The ex-dividend date is Friday, February 16th. AmerisourceBergen’s dividend payout ratio is 32.76%.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.